These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 21258768)
1. Promoter methylation of heat shock protein B2 in human esophageal squamous cell carcinoma. Chang X; Yamashita K; Sidransky D; Kim MS Int J Oncol; 2011 Apr; 38(4):1129-35. PubMed ID: 21258768 [TBL] [Abstract][Full Text] [Related]
2. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma. He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785 [TBL] [Abstract][Full Text] [Related]
3. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960 [TBL] [Abstract][Full Text] [Related]
4. Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma. Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119 [TBL] [Abstract][Full Text] [Related]
6. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus. Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529 [TBL] [Abstract][Full Text] [Related]
7. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation. Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344 [TBL] [Abstract][Full Text] [Related]
8. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma. Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536 [TBL] [Abstract][Full Text] [Related]
9. Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma. Li JS; Ying JM; Wang XW; Wang ZH; Tao Q; Li LL Chin J Cancer; 2013 Jan; 32(1):3-11. PubMed ID: 22572016 [TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma. Wang JX; He YL; Zhu ST; Yang S; Zhang ST World J Gastroenterol; 2011 Oct; 17(37):4225-30. PubMed ID: 22072855 [TBL] [Abstract][Full Text] [Related]
12. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma. Wang Y; Fang MZ; Liao J; Yang GY; Nie Y; Song Y; So C; Xu X; Wang LD; Yang CS Clin Cancer Res; 2003 Nov; 9(14):5257-63. PubMed ID: 14614007 [TBL] [Abstract][Full Text] [Related]
13. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients. Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma. Cui X; Zhao Z; Liu D; Guo T; Li S; Hu J; Liu C; Yang L; Cao Y; Jiang J; Liang W; Liu W; Li S; Wang L; Wang L; Gu W; Wu C; Chen Y; Li F J Exp Clin Cancer Res; 2014 Feb; 33(1):20. PubMed ID: 24528540 [TBL] [Abstract][Full Text] [Related]
15. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma. Sheyhidin I; Hasim A; Zheng F; Ma H Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465 [TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Kim MS; Yamashita K; Baek JH; Park HL; Carvalho AL; Osada M; Hoque MO; Upadhyay S; Mori M; Moon C; Sidransky D Cancer Res; 2006 Apr; 66(7):3409-18. PubMed ID: 16585162 [TBL] [Abstract][Full Text] [Related]
18. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750 [TBL] [Abstract][Full Text] [Related]
19. LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas. Zheng F; Hasim A; Anwer J; Niyaz M; Sheyhidin I Mol Biol Rep; 2013 Mar; 40(3):2069-75. PubMed ID: 23283737 [TBL] [Abstract][Full Text] [Related]
20. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma. Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]